Molecular pathways integral to normal cell functioning have been implicated in driving poor glioblastoma survival and resistance, including the insulin‐like growth factor (IGF) axis and the chaperone glucose‐regulated protein of 78 kDa (GRP78).13, 14, 15. This evidence concerns the gene HSPA5 and glioblastoma.